NCT01347255

A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to evaluate the anti-psoriatic effect of LEO 90100 cutaneous spray ointment, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.

Conditions

• Psoriasis Vulgaris

Interventions

Type	Name	Description
DRUG	LEO90100 cutaneous spray, ointment	once daily application, 4 weeks
DRUG	LEO 90100 cutaneous spray, ointment, vehicle with betamethasone dipropionate	once daily application, 4 weeks
DRUG	LEO 90100 cutaneous spray, ointment, vehicle	once daily application, 4 weeks
DRUG	Daivobet® ointment	once daily application, 4 weeks

Timeline

• Start date: 2011-05-01
• Primary completion: 2011-06-01
• Completion: 2011-06-01
• First posted: 2011-05-04
• Last updated: 2025-03-07
• Results posted: 2016-02-24

Locations

1 site across 1 country: France